Proteomics in cardiovascular surgery

Slides:



Advertisements
Similar presentations
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Advertisements

Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Manuel J. Antunes, MD, PhD, DSc 
A wolf in sheep's clothing
Expanding options to manage traumatic thoracic vascular injuries
Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant  Victor van Berkel, MD, PhD 
The days of future past  Neel K. Ranganath, MD, Aubrey C. Galloway, MD 
Jennifer Chung, MD, MSc, Maral Ouzounian, MD, PhD 
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Form ever follows function
Victor van Berkel, MD, PhD 
William M. DeCampli, MD, PhD 
Functional mitral stenosis after mitral valve repair is a true anatomic problem that originates from the time of surgery  Vincent Chan, MD, MPH, Thierry.
Multilevel data analysis: What? Why? How?
Marye J. Gleva, MD, Charles B. Huddleston, MD 
Go on-pump or off-pump in diabetic patients?
Resuscitation practices in cardiac surgery
Calcified amorphous tumor of left atrium
Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement  Ole Lund, MD, PhD, Martin Bland,
The lord of the rings  Antonio Miceli, MD, PhD 
Impact of prior hospital mortality versus surgical volume on mortality following surgery for congenital heart disease  Matthew E. Oster, MD, Matthew J.
Expanding left ventricular assist device use to patients with disabilities: The role of assistive technology  Juan A. Crestanello, MD  The Journal of.
STAT3, Cten, and lung cancer: Simultaneous excitement and caution
Intra-aortic balloon pumps and continuous flow left ventricular assist devices: Don't let balloon pumps overstay their welcome  Kevin G. Soucy, PhD, Steven.
Aditya K. Kaza, MD  The Journal of Thoracic and Cardiovascular Surgery 
Pierre P. Massion, MD, Richard M. Caprioli, PhD 
Left ventricular assist device therapy in a patient with hearing and speech disabilities  Sotirios Spiliopoulos, MD, PhD, Vera Hergesell, MD, Otto Dapunt,
Innovation and science: The future of valve design
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
It's not “just a shunt” but sometimes it should be…
Do we need a bibliometrician to know which way the wind is blowing?
A first start for lung transplantation?
Right ventricular failure after cardiac surgery: Why can't right ventricular assist device support fix the problem?  Francis D. Pagani, MD, PhD  The Journal.
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
Christopher M. Feindel, MD, MSc, Maral Ouzounian, MD, PhD 
Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD 
Leora B. Balsam, MD, Abe DeAnda, MD 
Niv Ad, MD, Lawrence M. Wei, MD 
Left sinus of Valsalva aneurysm: Rare disease, rarer presentation
Fueling the heart: Shifting the myocardial metabolome by targeting endothelial autophagy  Nicholas D. Andersen, MD  The Journal of Thoracic and Cardiovascular.
A fate worse than death  Jennifer S. Lawton, MD 
Marc Licker, MD, John Diaper, RA 
The Ross procedure: Time to reevaluate the guidelines
Video-assisted resection for lung cancer results in fewer complications  Lunxu Liu, PhD, MD, FRCS  The Journal of Thoracic and Cardiovascular Surgery 
Commentary: Do the right thing! Ethical versus legal
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Prognosis and “granularity”: Building on staging foundations?
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
Mitral repair failures are not the robot's fault!
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
The future of cardiac surgery training: A survival guide
Commentary: “Isn't cardiac surgery a team sport?”
Apparently, size matters…in congenital heart disease and brain injury
Ventricular assistant in restrictive cardiomyopathy: Making the right connection  Robert D.B. Jaquiss, MD  The Journal of Thoracic and Cardiovascular Surgery 
Spot the mesh: Six-month follow-up
The continuing challenge of congenital heart disease in China
Seeing is believing: A call for routine early postoperative hemodynamic transesophageal echocardiography monitoring after left ventricular assist device.
The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids  Paul.
“The more things change…”: The challenges ahead
Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know  Harold L. Lazar,
Apples remain apples NO matter what
Respect the aorta The Journal of Thoracic and Cardiovascular Surgery
The evolution of cardiothoracic critical care
Gastrointestinal bleeding after left ventricular assist device implantation: It is all about the platelets  Juan A. Crestanello, MD  The Journal of Thoracic.
Did you like Terminator 3 better than Terminator 2
A good chimney requires a good sweep
How do we follow up our patients
Lessons learned from Melody valve retrieved at transplantation
Paul Philipp Heinisch, MD, Thierry Carrel, MD 
Presentation transcript:

Proteomics in cardiovascular surgery Peter Matt, MD, Thierry Carrel, MD, Melanie White, PhD, Ivan Lefkovits, PhD, Jennifer Van Eyk, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 133, Issue 1, Pages 210-214.e1 (January 2007) DOI: 10.1016/j.jtcvs.2006.09.007 Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Outline of the relationship between the genome and proteome, showing the ways in which gene expression can be regulated or modified from transcription to posttranslation. The Journal of Thoracic and Cardiovascular Surgery 2007 133, 210-214.e1DOI: (10.1016/j.jtcvs.2006.09.007) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Two-dimensional gel pattern of a human left ventricular biopsy specimen. The patient subsequently underwent heart transplantation because of dilatative cardiomyopathy. The gel size measures 17 × 17 cm, the isoelectric point (pI) range is 3 to 10, and the molecular mass (Mr) range is 15 to 100 kd. There are approximately 600 protein spots on the 2-dimensional gel, which can be further identified with mass spectrometry. The Journal of Thoracic and Cardiovascular Surgery 2007 133, 210-214.e1DOI: (10.1016/j.jtcvs.2006.09.007) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure E1 Peptides resulting from tryptic digestion of a protein spot resolved by means of 2-dimensional gel electrophoresis are analyzed by using mass spectrometry. The resulting mass spectra are presented as a plot of signal intensity versus mass-to-charge ratio (m/z). The peptide corresponding to an m/z ratio of 1407.9 was selected for further analysis (inset). Fragmentation of peptide 1407.9 m/z by means of mass spectrometry allowed for amino acid sequence deduction (as denoted in red letters). Using the combination of matrix-assisted laser desorption ionization–time-of-flight analysis and time-of-flight/time-of-flight analysis, 72.6% of the protein sequence was covered, and the protein was finally identified as myoglobin (isoelectric point, 6.67; molecular mass, 17.1 kd). The Journal of Thoracic and Cardiovascular Surgery 2007 133, 210-214.e1DOI: (10.1016/j.jtcvs.2006.09.007) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions